Nu Skin CFO Resigns Amidst Operational Challenges; Interim CFO Appointed
NUS sits 33% above its 52-week low of $5.32 on elevated volume (3.0× avg).
Summary
Nu Skin's CFO, James D. Thomas, resigned, and Chelsea K. Lantz was appointed Interim CFO, effective March 18, 2026.
Key Events · Executive and Board Changes · NUS
-
CFO Resignation
James D. Thomas resigned from his position as Executive Vice President and Chief Financial Officer, effective March 17, 2026, to pursue an outside opportunity.
-
Interim CFO Appointment
Chelsea K. Lantz, the company's Vice President and Corporate Controller, was appointed Interim CFO, effective March 18, 2026. A search for a permanent CFO is underway.
-
Interim Compensation Details
As Interim CFO, Ms. Lantz will receive an annual salary of $300,000, a target incentive bonus of 35% of her annual salary, and a quarterly stipend of $25,000.
Analysis · NUS · Trade & Services
Nu Skin Enterprises announced the resignation of its Executive Vice President and Chief Financial Officer, James D. Thomas, effective March 17, 2026, to pursue an outside opportunity. This departure comes at a challenging time for the company, following a 14% revenue drop and declining sales force metrics reported in its recent 10-K. The Board has appointed Chelsea K. Lantz, the company's Vice President and Corporate Controller, as Interim CFO. While Ms. Lantz brings internal experience, the unexpected departure of a key financial executive during a period of operational challenges introduces uncertainty and highlights the need for a permanent replacement to guide the company's financial strategy.
At the time of this filing, NUS was trading at $7.10 on NYSE in the Trade & Services sector, with a market capitalization of approximately $342.7M. The 52-week trading range was $5.32 to $14.62. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.